Silver Diamine Fluoride Stops Cavities Without Drilling

A topical substance known as silver diamine fluoride (SDF) can halt the progression of cavities without the need for drilling, according to new research published in JAMA Pediatrics. This inexpensive treatment, applied in seconds at a dentist's office, presents a viable alternative to traditional cavity repair, even for infants. The study focused on SDF's effectiveness in treating cavities in over 800 children under the age of six. Results indicated that when applied every six months, SDF successfully stopped tooth decay in more than half of the participants' primary teeth. Unlike conventional cavity treatments that involve drilling away decayed tooth structure, SDF is simply painted onto the affected tooth surface. Silver diamine fluoride has been utilized globally for many years. In the United States, it received FDA approval in 2014 primarily for treating tooth sensitivity, although dentists have been using it off-label for cavity treatment. This no-drill option holds significant potential for reducing tooth decay, a condition that affects nearly half of children in the U.S. and can lead to pain, infections, and missed school days due to dental appointments. Margherita Fontana, a professor at the University of Michigan School of Dentistry and the study's lead researcher, emphasized the need for robust evidence demonstrating both the efficacy and safety of SDF to ensure wider adoption. She stated, "If we want more children and families to benefit from this treatment, we need rigorous evidence showing both that it works and that it’s safe." Fontana further highlighted the importance of collected data from U.S. populations for broader implementation, particularly in medical settings, noting, "From a public health perspective, if we want broader implementation across the United States, including in medical settings, we need carefully collected data in U.S. populations, and we now have that." The research, a collaborative effort between the University of Michigan, NYU College of Dentistry, and the University of Iowa, is anticipated to pave the way for SDF's formal FDA approval as a cavity treatment in the United States. This development is crucial given the high prevalence of childhood tooth decay and the associated health and educational consequences. The study's findings provide critical data supporting SDF's role in pediatric dental care, potentially transforming how cavities are managed in young populations and reducing the reliance on invasive drilling procedures.